Clinical Trial Update: Post-registration Trial of the Non-immunogenic Staphylokinase in Acute Ischemic Stroke (FORPI Registry)

View source ↗

Summary

Post-registration registry update for the non-immunogenic staphylokinase trial in acute ischemic stroke (FORPI Registry). The study status is listed as complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Non-immunogenic staphylokinase (staphylokinase)

Snippet

Sponsor: Supergene, LLC | Conditions: Acute Ischemic Stroke | Status: COMPLETED